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Background
The peach Lipid Transfer Protein (LTP), Pru p 3, is con-
sidered to be a major allergen in peach allergy, but sensiti-
zation to it is almost always present in LTP-syndrome.
Thus, detection of Pru p 3 specific IgE (sIgE) is frequent in
routine peach and/or LTP allergy diagnosis. ImmunoCAP
is one of the most frequent immunoassays for specific IgE
detection, with a 0.1kU/L detection limit, although
0.35kU/L has traditionally been adopted as the positivity
cutoff. The aim was to analyze the prevalence and clinical
relevance of low levels of Pru p 3 sIgE in a cohort of
patients diagnosed of peach sensitization.
Methods
Pru p 3 sIgE levels (f420, ImmunoCAP) were analyzed in
patients with peach sensitization according to positive skin
prick test. Data about clinical symptoms with plant-food,
cofactor contribution and plant-foods sensitization were
collected on 2 subsets of these patients: below 0.35kU/L
(n=33, Group A) and above 17.5kU/L (n=25, Group B).
Results
319 patients had Pru p 3 sIgE levels above 0.1kU/L. Of
these, 42 (13.2%) had values between 0.1-0.35kU/L, 21
(6.6%) between 0.36-0.75kU/L (class 1), 63 (19.8%)
between 0.76-3.5kU/L (class 2), 79 (24.8%) between 3.6-
17kU/L (class 3), 28 (8.7%) between 17.5-50kU/L (class
4) and 2 (0.6%) between 50.5-100kU/L (class 5).
According to the clinical history of groups A and B, con-
tact urticaria was reported in 9 (27.3%) patients and in 5
(20%), respectively. 16 patients tolerated pulp-peach in A
(48.5%) and 9 (36%) in B. Of those with symptoms upon
peach ingestion (A: 17 and B: 16), 5 (29.4%) have only pre-
sented oral allergy syndrome in A, whereas only 2 (12.5%)
in B. The rest had episodes of systemic reactions [(A vs. B
in %): urticaria/angioedema (23.5 vs. 31.3%), gastrointest-
inal disorder (17.6 vs. 56.3%), and anaphylaxis (35.3 vs.
18.8%)]. Patients in B had a broader spectrum of sensitiza-
tions to other plant-foods than A and presented more
symptoms with plant-foods other than peach. Cofactors,
NSAIDs and exercise, were involved in 3 (17.6%) patients
in A, whereas in 8 (50%) in B.
Conclusion
Pru p 3 sIgE below 0.35kU/L should not be regarded as
irrelevant in patients with a clinical suspicion of peach
and/or LTP allergy. The role of cofactors seems to be
relevant in the expression of LTP allergic symptoms, but
not to be related to IgE specific levels. IgE levels do not
correlate with severity of symptoms, but seem to corre-
late with a broader spectrum of sensitization to plant-
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